Luo N - Search Results

1

Oncoplastic breast-conserving surgery improves cosmetic outcomes without increasing recurrence risk compared to modified radical mastectomy in early breast cancer patients: development and validation of a recurrence risk prediction model.

Xu Y, Cao J, Gong K, Li S, Liu Y, Xiong F, Pan Y, Chen M, Gong J, Luo N, Yuan S. Xu Y, et al. Among authors: luo n. Am J Cancer Res. 2023 Sep 15;13(9):4259-4268. eCollection 2023. Am J Cancer Res. 2023. PMID: 37818068 Free PMC article.

2

Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer.

Xu Y, Yuan S, Chen M, Gong K, Liu Y, Li S, Xiong F, Pan Y, Cao J, Gong J, Luo N. Xu Y, et al. Among authors: luo n. Gland Surg. 2022 Sep;11(9):1489-1496. doi: 10.21037/gs-22-434. Gland Surg. 2022. PMID: 36221275 Free PMC article.

3

Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy.

Yuan JQ, Wang SM, Tang LL, Mao J, Wu YH, Hai J, Luo SY, Ou HY, Guo L, Liao LQ, Huang J, Li Y, Xiao Z, Zhang KJ, Luo N, Chen FY. Yuan JQ, et al. Among authors: luo n, luo sy. Breast Cancer Res Treat. 2015 Jun;151(2):405-13. doi: 10.1007/s10549-015-3418-z. Epub 2015 May 9. Breast Cancer Res Treat. 2015. PMID: 25956059

4

Construction and validation of a risk prediction model for clinical axillary lymph node metastasis in T1-2 breast cancer.

Luo N, Wen Y, Zou Q, Ouyang D, Chen Q, Zeng L, He H, Anwar M, Qu L, Ji J, Yi W. Luo N, et al. Sci Rep. 2022 Jan 13;12(1):687. doi: 10.1038/s41598-021-04495-y. Sci Rep. 2022. PMID: 35027588 Free PMC article.

5

3D reconstruction based novel methods are more effective than traditional clinical assessment in breast cancer axillary lymph node metastasis prediction.

Qu L, Chen Q, Luo N, Zhao P, Zou Q, Mei X, Liu Z, Yi W. Qu L, et al. Among authors: luo n. Sci Rep. 2022 Jul 20;12(1):12425. doi: 10.1038/s41598-022-16380-3. Sci Rep. 2022. PMID: 35858979 Free PMC article.

6

A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.

Hu Y, He Y, Luo N, Li X, Guo L, Zhang K. Hu Y, et al. Among authors: luo n. Cancer Biol Ther. 2023 Dec 31;24(1):2235768. doi: 10.1080/15384047.2023.2235768. Cancer Biol Ther. 2023. PMID: 37548553 Free PMC article.

7

The application of aptamer 5TR1 in triple negative breast cancer target therapy.

Luo S, Wang S, Luo N, Chen F, Hu C, Zhang K. Luo S, et al. Among authors: luo n. J Cell Biochem. 2018 Jan;119(1):896-908. doi: 10.1002/jcb.26254. Epub 2017 Aug 17. J Cell Biochem. 2018. PMID: 28671278

8

YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.

Li X, Zhang K, Hu Y, Luo N. Li X, et al. Among authors: luo n. Am J Pathol. 2023 Apr;193(4):442-455. doi: 10.1016/j.ajpath.2022.12.010. Epub 2023 Jan 18. Am J Pathol. 2023. PMID: 36681189 Free article.

9

L-norvaline affects the proliferation of breast cancer cells based on the microbiome and metabolome analysis.

Zhu Q, Zai H, Zhang K, Zhang X, Luo N, Li X, Hu Y, Wu Y. Zhu Q, et al. Among authors: luo n. J Appl Microbiol. 2022 Aug;133(2):1014-1026. doi: 10.1111/jam.15620. Epub 2022 May 25. J Appl Microbiol. 2022. PMID: 35543360

10

Tanshinone IIA destabilizes SLC7A11 by regulating PIAS4-mediated SUMOylation of SLC7A11 through KDM1A, and promotes ferroptosis in breast cancer.

Luo N, Zhang K, Li X, Hu Y, Guo L. Luo N, et al. J Adv Res. 2024 Apr 12:S2090-1232(24)00152-8. doi: 10.1016/j.jare.2024.04.009. Online ahead of print. J Adv Res. 2024. PMID: 38615741 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,548 results

Search Page